On January 17, 2024, Epicore Biosystems, Inc. closed the transaction. The transaction included participation from new investors, Pegasus Tech Ventures, Inc. and Denka Company Limited. The company has raised $1,539,999 pursuant to exemption provided under Regulation D from 2 investors
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,304 JPY | -0.41% | -1.48% | -7.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.69% | 1.29B | |
+5.92% | 104B | |
-2.51% | 64.55B | |
+51.90% | 41.5B | |
+18.29% | 40.01B | |
+7.77% | 33.03B | |
+12.44% | 20.11B | |
+16.99% | 17.52B | |
+20.27% | 15.51B | |
+10.05% | 15.34B |
- Stock Market
- Equities
- 4061 Stock
- News Denka Company Limited
- Epicore Biosystems, Inc. announced that it has received $10.006315 million in funding from Pegasus Tech Ventures, Inc., Denka Company Limited